Anna Ractliffe
Stock Analyst at Bank of America Securities
(2.22)
# 2,958
Out of 4,345 analysts
11
Total ratings
66.7%
Success rate
3.7%
Average return
Main Sectors:
Stocks Rated by Anna Ractliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: FME Fresenius Medical Care AG | Reiterated: Sell | €32.00 | $37.31 | -14.23% | 6 | May 14, 2026 | |
| EPA: BIM bioMérieux S.A. | Upgraded: Hold | €115.00 | $71.90 | +59.94% | 1 | Dec 12, 2025 | |
| LON: RS1 RS Group plc | Upgraded: Buy | 730p | $682.00 | n/a | 1 | May 13, 2025 | |
| BME: FDR Fluidra, S.A. | Upgraded: Buy | €21.00 → €26.00 | $19.04 | n/a | 2 | Apr 10, 2025 | |
| AMS: LIGHT Signify N.V. | Upgraded: Buy | €29.00 | $20.70 | n/a | 1 | Nov 6, 2024 |
Fresenius Medical Care AG
May 14, 2026
Reiterated: Sell
Price Target: €32.00
Current: $37.31
Upside: -14.23%
bioMérieux S.A.
Dec 12, 2025
Upgraded: Hold
Price Target: €115.00
Current: $71.90
Upside: +59.94%
RS Group plc
May 13, 2025
Upgraded: Buy
Price Target: 730p
Current: $682.00
Upside: n/a
Fluidra, S.A.
Apr 10, 2025
Upgraded: Buy
Price Target: €21.00 → €26.00
Current: $19.04
Upside: n/a
Signify N.V.
Nov 6, 2024
Upgraded: Buy
Price Target: €29.00
Current: $20.70
Upside: n/a